Titan Biotech Limited

BSE:524717 Stock Report

Market Cap: ₹6.2b

Titan Biotech Management

Management criteria checks 2/4

Titan Biotech's CEO is Naresh Singla, appointed in Apr 2018, has a tenure of 6.67 years. total yearly compensation is ₹4.80M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.54% of the company’s shares, worth ₹33.25M. The average tenure of the management team and the board of directors is 5.3 years and 2.2 years respectively.

Key information

Naresh Singla

Chief executive officer

₹4.8m

Total compensation

CEO salary percentage100.0%
CEO tenure6.7yrs
CEO ownership0.5%
Management average tenure5.3yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Naresh Singla's remuneration changed compared to Titan Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹253m

Jun 30 2024n/an/a

₹251m

Mar 31 2024₹5m₹5m

₹249m

Dec 31 2023n/an/a

₹248m

Sep 30 2023n/an/a

₹209m

Jun 30 2023n/an/a

₹227m

Mar 31 2023₹5m₹5m

₹248m

Dec 31 2022n/an/a

₹249m

Sep 30 2022n/an/a

₹268m

Jun 30 2022n/an/a

₹249m

Mar 31 2022₹5m₹5m

₹217m

Dec 31 2021n/an/a

₹241m

Sep 30 2021n/an/a

₹255m

Jun 30 2021n/an/a

₹263m

Mar 31 2021₹5m₹5m

₹303m

Dec 31 2020n/an/a

₹285m

Sep 30 2020n/an/a

₹236m

Jun 30 2020n/an/a

₹178m

Mar 31 2020₹5m₹5m

₹71m

Dec 31 2019n/an/a

₹58m

Sep 30 2019n/an/a

₹49m

Jun 30 2019n/an/a

₹46m

Mar 31 2019₹4m₹4m

₹35m

Compensation vs Market: Naresh's total compensation ($USD56.15K) is above average for companies of similar size in the Indian market ($USD42.22K).

Compensation vs Earnings: Naresh's compensation has been consistent with company performance over the past year.

CEO

Naresh Singla (65 yo)

6.7yrs

Tenure

₹4,800,000

Compensation

Mr. Naresh Kumar Singla serves as Managing Director of Titan Biotech Limited since April 1, 2018 and its Director since February 18, 1992. Mr. Singla joined the Titan Biotech Limited on February 18, 1992....

Leadership Team

NamePositionTenureCompensationOwnership
Naresh Singla
MD & Executive Director6.7yrs₹4.80m0.54%
₹ 33.2m
Suresh Singla
MD & Executive Director6.7yrs₹4.80m1.28%
₹ 78.9m
Prem Gupta
Chief Financial Officerno data₹1.85mno data
Charanjit Singh
Company Secretaryno data₹2.27mno data
Raja Singla
Senior VP of Production & Whole Time Director5.3yrs₹12.00m0.74%
₹ 45.6m
Udit Singla
Whole Time Director1.2yrs₹6.00m0.61%
₹ 37.4m
Shivom Singla
Whole Time Director1.2yrs₹6.00m0.43%
₹ 26.4m
Madhu Singla
Vice President of Admn.no datano datano data

5.3yrs

Average Tenure

64yo

Average Age

Experienced Management: 524717's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Naresh Singla
MD & Executive Director32.8yrs₹4.80m0.54%
₹ 33.2m
Suresh Singla
MD & Executive Director32.8yrs₹4.80m1.28%
₹ 78.9m
Raja Singla
Senior VP of Production & Whole Time Director2.2yrs₹12.00m0.74%
₹ 45.6m
Udit Singla
Whole Time Director1.2yrs₹6.00m0.61%
₹ 37.4m
Shivom Singla
Whole Time Director1.2yrs₹6.00m0.43%
₹ 26.4m
Manju Singla
Non-Executive Woman Director23.5yrsno data0.86%
₹ 53.2m
Supriya Singla
Non-Executive Non-Independent Director12.2yrsno data0.66%
₹ 40.7m
Rohit Jain
Non-Executive Independent Chairman3.4yrsno datano data
Abhishek Agarwal
Independent Non-Executive Director2.2yrs₹34.50kno data
Dhairya Madan
Independent Non-executive Director1.2yrs₹30.00kno data
Brijesh Singh
Independent Non-executive Director1.2yrs₹30.00kno data

2.2yrs

Average Tenure

35yo

Average Age

Experienced Board: 524717's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 12:21
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Titan Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution